Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Preferred Stock Liabilities: 2023

Historic Preferred Stock Liabilities for Camp4 Therapeutics (CAMP) over the last 1 years, with Dec 2023 value amounting to $162.1 million.

  • Camp4 Therapeutics' Preferred Stock Liabilities changed negligibly% to $162.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $162.1 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $162.1 million for FY2023, which is N/A change from last year.
  • Camp4 Therapeutics' Preferred Stock Liabilities amounted to $162.1 million in FY2023.
  • Camp4 Therapeutics' 5-year Preferred Stock Liabilities high stood at $162.1 million for FY2023, and its period low was $162.1 million during FY2023.
  • In the last 1 years, Camp4 Therapeutics' Preferred Stock Liabilities had a median value of $162.1 million in 2023 and averaged $162.1 million.